{"id":"https://openalex.org/W7225201029","doi":"https://doi.org/10.3389/fphar.2026.1853907","title":"Effects of Chamaecostus cuspidatus leaf extract and p-coumaric acid on diabetes-associated vascular injury in high-fat diet/streptozotocin- induced wistar rats","display_name":"Effects of Chamaecostus cuspidatus leaf extract and p-coumaric acid on diabetes-associated vascular injury in high-fat diet/streptozotocin- induced wistar rats","publication_year":2026,"publication_date":"2026-11-03","ids":{"openalex":"https://openalex.org/W7225201029","doi":"https://doi.org/10.3389/fphar.2026.1853907"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1853907","doi":"https://doi.org/10.3389/fphar.2026.1853907","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1853907","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1853907/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1853907/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072398377","display_name":"Menaka Priya Balaji","orcid":"https://orcid.org/0000-0002-0494-6579","observed_orcids":["https://orcid.org/0000-0002-0494-6579"]},"institutions":[{"id":"https://openalex.org/I876193797","display_name":"Vellore Institute of Technology University","ror":"https://ror.org/00qzypv28","country_code":"IN","type":"education","lineage":["https://openalex.org/I876193797"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Menaka Priya Balaji","raw_affiliation_strings":["Department of Biomedical Science, School of Bioscience and Technology, Vellore Institute of Technology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Science, School of Bioscience and Technology, Vellore Institute of Technology","institution_ids":["https://openalex.org/I876193797"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160457753","display_name":"Devi Rajeswari V.","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I876193797","display_name":"Vellore Institute of Technology University","ror":"https://ror.org/00qzypv28","country_code":"IN","type":"education","lineage":["https://openalex.org/I876193797"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Devi Rajeswari V.","raw_affiliation_strings":["Department of Biomedical Science, School of Bioscience and Technology, Vellore Institute of Technology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Science, School of Bioscience and Technology, Vellore Institute of Technology","institution_ids":["https://openalex.org/I876193797"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5160457753"],"corresponding_institution_ids":["https://openalex.org/I876193797"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.87481364,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14521","display_name":"Medicinal Plant Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-coumaric-acid","display_name":"p-coumaric acid","score":0.9679999947547913},{"id":"https://openalex.org/keywords/diabetic-vascular-injury","display_name":"diabetic vascular injury","score":0.7559999823570251},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9769999980926514},{"id":"https://openalex.org/keywords/high-fat-diet-streptozotocin-induced-diabetes","display_name":"high-fat diet and streptozotocin-induced diabetes","score":0.8690000176429749},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9559999704360962},{"id":"https://openalex.org/keywords/antioxidant-enzymes","display_name":"antioxidant enzymes","score":0.9850000143051147},{"id":"https://openalex.org/keywords/txnip","display_name":"TXNIP","score":0.8799999952316284},{"id":"https://openalex.org/keywords/nlrp3-inflammasome","display_name":"NLRP3 inflammasome","score":0.9909999966621399},{"id":"https://openalex.org/keywords/caspase-1","display_name":"caspase-1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5090000033378601},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7730000019073486},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.925000011920929},{"id":"https://openalex.org/keywords/leaf-extract","display_name":"leaf extract","score":0.6200000047683716},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8370000123977661}],"concepts":[{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.8668000102043152},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.6952999830245972},{"id":"https://openalex.org/C544855455","wikidata":"https://www.wikidata.org/wiki/Q1070952","display_name":"Histopathology","level":2,"score":0.6894999742507935},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.5149999856948853},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4925999939441681},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48410001397132874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47029998898506165},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.46299999952316284},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4345000088214874},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38659998774528503},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38609999418258667},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35760000348091125},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.3506999909877777},{"id":"https://openalex.org/C2777663904","wikidata":"https://www.wikidata.org/wiki/Q988343","display_name":"Blood vessel","level":2,"score":0.32910001277923584},{"id":"https://openalex.org/C2777466421","wikidata":"https://www.wikidata.org/wiki/Q1266890","display_name":"Vascular disease","level":2,"score":0.3280999958515167},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.32519999146461487},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3149999976158142},{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.30489999055862427},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.29600000381469727},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.2906000018119812},{"id":"https://openalex.org/C57600042","wikidata":"https://www.wikidata.org/wiki/Q227564","display_name":"Oxidative phosphorylation","level":2,"score":0.2808000147342682}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fphar.2026.1853907","doi":"https://doi.org/10.3389/fphar.2026.1853907","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1853907","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1853907/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1853907","doi":"https://doi.org/10.3389/fphar.2026.1853907","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1853907","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1853907/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225201029.pdf","grobid_xml":"https://content.openalex.org/works/W7225201029.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1991030168","https://openalex.org/W2009435405","https://openalex.org/W2018607502","https://openalex.org/W2039762060","https://openalex.org/W2060194897","https://openalex.org/W2069132215","https://openalex.org/W2077945404","https://openalex.org/W2078047202","https://openalex.org/W2088866343","https://openalex.org/W2096795975","https://openalex.org/W2114918609","https://openalex.org/W2141438284","https://openalex.org/W2158106881","https://openalex.org/W2202819904","https://openalex.org/W2471605942","https://openalex.org/W2522951514","https://openalex.org/W2883141736","https://openalex.org/W2893428475","https://openalex.org/W3004046724","https://openalex.org/W3042519842","https://openalex.org/W3124620391","https://openalex.org/W3193325801","https://openalex.org/W4224256560","https://openalex.org/W4236357753","https://openalex.org/W4295346553","https://openalex.org/W4296816736","https://openalex.org/W4391253306","https://openalex.org/W4411613295"],"related_works":["https://openalex.org/W4409209017","https://openalex.org/W2184585866","https://openalex.org/W2033698407","https://openalex.org/W2906271154","https://openalex.org/W3202518408","https://openalex.org/W2918339716","https://openalex.org/W2100137915","https://openalex.org/W4408967073","https://openalex.org/W4405941210","https://openalex.org/W2027860621"],"abstract_inverted_index":{"Endothelial":[0],"dysfunction":[1],"plays":[2],"a":[3,45,51,115,163,266],"significant":[4],"role":[5],"in":[6,42,44,99,166,173,180,232],"the":[7,29,61,93,100,120,123,130,147,158,254],"cardiovascular":[8],"consequences":[9],"of":[10,31,60,78,83,95,133,226,241],"diabetes.":[11],"Persistent":[12],"hyperglycemia":[13],"and":[14,20,36,41,54,75,81,86,109,122,129,177,190,195,202,218,234,246,260],"dyslipidaemia":[15],"may":[16,261],"increase":[17],"oxidative":[18,68,235],"stress":[19,69],"inflammatory":[21],"responses.":[22],"The":[23,58,88],"present":[24],"study":[25],"aimed":[26],"to":[27],"evaluate":[28],"effects":[30,59,252],"Chamaecostus":[32],"cuspidatus":[33,243],"leaf":[34,102,244],"extract":[35,103,121,245],"p":[37,96,125,134,247],"-coumaric":[38,97,126,135,248],"acid":[39,98,127,136,249],"alone":[40],"combination":[43,148,239,267],"diabetic":[46,145,159],"rat":[47],"model":[48],"induced":[49],"by":[50,65,141,193,204,214],"high-fat":[52],"diet":[53],"streptozotocin":[55],"(40":[56],"mg/kg).":[57],"treatments":[62],"were":[63],"examined":[64],"biochemical":[66],"parameters,":[67,70],"antioxidant":[71,184],"enzyme":[72],"activities,":[73],"histopathology":[74],"immunohistochemical":[76],"assessment":[77],"vascular":[79,211,255],"morphology":[80],"immunoreactivity":[82],"TXNIP,":[84,216],"NLRP3":[85],"caspase-1.":[87],"analytical":[89],"findings":[90],"tentatively":[91],"supported":[92],"presence":[94],"methanolic":[101],"based":[104],"on":[105,253],"FTIR,":[106],"GC-":[107],"MS":[108],"HPLC":[110,112],"investigations.":[111],"examination":[113,207],"indicated":[114],"similar":[116],"retention":[117],"time":[118],"between":[119],"authentic":[124],"standard,":[128],"calculated":[131],"concentration":[132],"equivalents":[137],"was":[138,150],"15.30":[139],"\u03bcg/mL":[140],"single-point":[142],"comparison.":[143],"In":[144,237],"rats,":[146],"treatment":[149],"associated":[151,257],"with":[152,157,171,186,230,258],"improved":[153],"metabolic":[154,233],"parameters":[155],"compared":[156],"disease":[160],"control,":[161],"including":[162],"74%":[164],"reduction":[165],"final":[167],"blood":[168],"glucose,":[169],"together":[170,229],"reductions":[172],"total":[174],"cholesterol,":[175],"triglycerides":[176],"an":[178],"improvement":[179],"HDL-C.":[181],"Treatment":[182],"enhanced":[183],"defence,":[185],"SOD,":[187],"CAT,":[188],"GSH":[189],"GPx":[191],"increasing":[192],"41%\u2013100%,":[194],"decreased":[196],"oxidative-stress":[197],"indicators,":[198],"such":[199],"as":[200,265],"ROS":[201],"MDA,":[203],"38%\u201353%.":[205],"Histopathological":[206],"demonstrated":[208],"comparatively":[209],"preserved":[210],"architecture,":[212],"accompanied":[213],"reduced":[215],"NLRP3,":[217],"caspase-1":[219],"immunoreactivity.":[220],"This":[221],"finding":[222],"suggests":[223],"altered":[224],"expression":[225],"inflammation-associated":[227],"markers":[228],"improvements":[231],"state.":[236],"conclusion,":[238],"therapy":[240],"C.":[242],"exhibited":[250],"positive":[251],"alterations":[256],"diabetes":[259],"deserve":[262],"further":[263],"exploration":[264],"method.":[268]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}